Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

Core Viewpoint - Intuitive has received FDA clearance for the da Vinci Single Port (SP) surgical system for transanal local excision/resection, enhancing its capabilities in colorectal surgery and offering a minimally invasive option for patients [1][4]. Company Overview - Intuitive is a global leader in minimally invasive care and robotic-assisted surgery, headquartered in Sunnyvale, California [8]. - The company has developed robotic-assisted technology for 30 years, with nearly 17 million procedures performed using its systems and approximately 90,000 surgeons trained [7]. Product Details - The da Vinci SP system is designed for precise navigation in narrow body cavities, allowing surgeons to control multiple instruments and a high-definition camera through a single entry point [2]. - This system addresses challenges in laparoscopic transanal minimally invasive surgery, improving ergonomics and access to lesions [3]. Clinical Impact - The FDA clearance for the da Vinci SP system is expected to positively impact patient outcomes by enabling better preservation of healthy tissue and accelerating recovery [4]. - The system supports a range of colorectal interventions, complementing Intuitive's existing offerings like da Vinci 5 and da Vinci Xi [5]. Evidence and Approval - Over 500 peer-reviewed publications support the safety and efficacy of the da Vinci SP system, which is also cleared for various procedures in urology and other surgical disciplines [6].